Skip To Main Content

Lunsumio (mosunetuzumab-axgb)

Publications icon

Publications

Visit PubMed.gov to browse a listing of published scientific literature about Lunsumio™.

Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study
Budde LE, Sehn LH, Matasar M, et al. Lancet Oncol 2022;23(8):1055-1065.

VIEW

A Genentech Medical Science Liaison in your area can assist with medical questions about Lunsumio™ and other Genentech products.

Scientific congresses icon

Scientific Congresses

Genentech maintains a presence at in-person and virtual scientific congresses worldwide. Find Genentech-sponsored posters and presentations from recent congresses at Medically.gene.com.

December 10-13, 2022
Onsite/virtual

July 18-22, 2022
Onsite

June 9-12, 2022
Onsite/virtual

June 3-7, 2022
Onsite/virtual

December 11-14, 2021
Onsite/virtual

June 18-22, 2021
Virtual

June 9-17, 2021
Virtual

Clinical trials icon

Clinical Trials

Find information about active clinical research for Lunsumio™ at ClinicalTrials.gov and information about our research at Genentech Clinical Trials.

Additional resources icon

Additional Resources

For additional information or assistance regarding Lunsumio™, use the links below.

Connect with a Medical Science Liaison

Browse the Genentech Medical Information Library